Objective: Sexual functioning is an important component of women's lives. The extent to which the menopausal transition is associated with decreased sexual functioning remains inconclusive. This study seeks to determine if advancing through the menopausal transition is associated with changes in sexual functioning.
S exual functioning is an important component of women's lives and has increasingly received public health, pharmaceutical, and medical attention. 1 More than 75% of the middle-aged women in the Study of Women's Health Across the Nation (SWAN) reported that sex was moderately to extremely important. 2 Sexual functioning, however, declines with age, 1,3<8 leading to much debate on the contribution of menopause to sexual activity and functioning among women.
The menopausal transition is a gradual change from premenopause to postmenopause, which is defined retrospectively after 12 months of amenorrhea. Some evidence suggests that sexual functioning declines over the menopausal transition, yet whether this decline is due to menopause, aging, or other variables remains inconclusive. 3,4,9<12 Understanding factors that affect sexual functioning can help clinicians counsel women. Most studies in this area are crosssectional, not large enough to separate the effects of menopause from chronological aging, and/or do not include relevant covariates.
Relationship, psychosocial, and health factors are often reported as more important determinants of sexual function than ovarian function. Primary factors associated with a woman's sexual function include the availability of a partner, 10 ,13<15 relationship quality, 9,16<19 psychological function, 1,10,19<22 health, 13, 20, 23 and race/ethnicity. 16, 24 Longitudinal data from SWAN provide the opportunity to disentangle the role of menopause from chronological aging in sexual functioning and activity among a multiethnic sample while also examining concurrent social, health, and psychological parameters. With 6 years of follow-up data, this large cohort of 3,302 women at baseline provides the opportunity to examine changes in sexual functioning as women progress through the menopausal transition. The primary research question was as follows: Independent of chronological aging and time, is advancing through the menopausal transition associated with a decline in sexual functioning? Secondarily, we were interested in (1) whether menopausal symptoms (hot flashes, night sweats, vaginal dryness) contributed to a dimunition in sexual functioning over and above menopause status and (2) the relative contribution of menopause and other health, social, psychological, and relationship factors to sexual funtioning.
METHODS
The Study of Women's Health Across the Nation is a multiethnic observational cohort study of the menopausal transition in 3,302 women at seven sites across the United States. 25 Details of enrollment have been previously reported. 25 Baseline eligibility criteria included the following: age 42 to 52 years, intact uterus and at least one ovary, not currently using exogenous hormones affecting ovarian function, at least one menstrual period in the previous 3 months, and self-identification with a site's designated racial/ ethnic group. Half of each site's sample consisted of white women and the other half was from one minority population (African American, Japanese, Chinese, or Hispanic).
Baseline and standardized assessments were completed annually in a clinic setting where physiological and selfreport measures were administered by trained interviewers. Study forms were available in English, Cantonese, Japanese, and Spanish, and bilingual staff was used, as appropriate. Each site received institutional review board approval, and all participants gave written informed consent.
Measures
Sexuality outcome variables were measured at each study visit from baseline to visit 06 using a 20-item questionnaire designed to address sexual activity and function in women with and without partners. The questionnaire, which was selfadministered and returned to staff in a sealed envelope, was derived from several sources as previously described 16 : The Massachusetts Women's Health Study, 20 The National Health and Social Life Survey, 26 the National Survey of Family Growth, 27 and the Women's Health Initiative Daily Life Form. 28 Variables of interest fall into the domains of importance of sex, sexual desire, frequency of activities (sexual intercourse and masturbation), physical pleasure, emotional satisfaction with partner, arousal, and pain. All questions were asked on 5-point Likert scales. All study women were asked how important was sex in their lives (not at all to extremely), how often they felt desire in the past 6 months to engage in any form of sexual activity either alone or with a partner (not at all to daily), frequency of engaging in masturbation in the past 6 months (not at all to daily), and if they had engaged in sexual activities with a partner in the last 6 months (yes/no). Respondents who reported having engaged in sexual activities with a partner in the last six months were asked about frequency of sexual intercourse and arousal during sexual activity (not at all to daily) and degree of emotional satisfaction and physical pleasure from their relationship with a partner (not at all to extremely). Women who reported having sexual intercourse in the past 6 months were also asked about frequency of vaginal or pelvic pain during intercourse (not at all to daily).
At each study visit, menopause status was classified as premenopausal (menses in previous 3 mo with no change in menstrual regularity in preceding year), early perimenopausal (menses in previous 3 mo and changes in regularity in past year), late perimenopausal (no menses in previous 3 mo but menses in previous 11 mo), or postmenopausal (12 or more months of amenorrhea). Women who underwent a bilateral oophorectomy (n = 119) were classified as surgically menopausal. Menopause status was not classifiable for women who had a hysterectomy but kept at least one ovary before being classified as postmenopausal, and they were omitted from the time of surgery onward (n = 80). Women who reported having taken hormone therapy in the previous 12 months were classified as current hormone therapy users, whereas past users were classified as former hormone therapy users. Among premenopausal and perimenopausal women, hormone therapy use classification was irrespective of menopause status because once a woman begins hormone therapy use, menopause status cannot be determined.
Covariates included age (at baseline), time (since baseline), variables related to sexual functioning in our baseline analyses, 16 and variables that others have found related to sexual functioning. Covariates were organized as follows: menopausal factors (hot flashes, night sweats, vaginal dryness, use of lubricants during intercourse), social factors (race/ethnicity, education, marital status, change in relationship status, having children at home), health and lifestyle factors (self-reported health, alcohol consumption, body mass index [BMI], and cigarette smoking), and psychological factors (attitudes toward aging and menopause, anxiety, depressive symptoms, and importance of sex).
The frequency of experiencing hot flashes, night sweats, and vaginal dryness in the past 2 weeks (not at all, 1-5 d, and 6-14 d) was assessed at each study visit as part of a general symptom list. Women who were sexually active were asked how often they had used lubricants in the past 6 months. Overall perceived health (excellent to poor) was selfassessed annually. Alcohol intake was assessed at baseline. 29, 30 At each interview, BMI was calculated as weight in kilograms divided by height in meters squared. Validated questions were used to obtain information on current smoking status. 31 Attitudes toward aging and menopause (highly positive, slightly positive, or neutral/negative) were assessed at baseline using the scale previously developed. 32 The Center for Epidemiologic Studies Depression Scale was used annually to assess depressive symptoms. 33 Anxiety, assessed annually, was the summed score of the number of days in the past 2 weeks in which four symptoms (irritability or grouchiness, feeling tense or nervous, heart racing or pounding, fearful for no reason) were experienced. 34 All covariates, except BMI, were assessed by self-report. In addition, study site was included in all adjusted models because it was a factor in the study sampling design.
Statistical analyses
Univariate models, followed by models adjusted for baseline age and chronological aging, provided an initial assessment of changes in sexual functioning domains across the menopausal transition. Multivariable models were constructed for all sexual functioning domains. Analyses were based on three subsamples of the SWAN cohort. The primary sample, used for analyses of desire, importance of sex, and masturbation, included 3,288 participants with sexual functioning data from at least one visit. The mean (SD) number of observations per woman was 5.5 (2.0) out of a total of seven possible visits. Data from visits at which women reported having engaged in sexual activity with a partner formed the subset for analysis of arousal, emotional satisfaction, physical pleasure, and frequency of intercourse (n = 2,789 women, mean (SD) of 5.4 (2.1) observations per woman). By necessity, analysis of pain during intercourse was restricted to visits at which women reported having had any sexual intercourse during the past 6 months (n = 2,744, mean [SD] of 5.3 [2.1] observations per woman).
For all domains except pain and masturbation, the highest and lowest Likert scale responses were infrequently reported; therefore, extreme groups were collapsed with adjacent response categories. More frequent experiences of vaginal or pelvic pain and masturbation were infrequently endorsed, so these response categories were collapsed. The resultant three-level ordinal variables were initially modeled using multivariable partial proportional odds models. However, these models showed little substantive difference in terms of results and added considerable complexity to model interpretation, relative to results from logistic regression models based on dichotomized outcomes. Hence, the latter are reported.
Separate analyses modeled the probability of feeling sexual desire at least once weekly; engaging in sexual intercourse at least once weekly; masturbating at all; feeling aroused during sexual activity always or almost always; feeling vaginal or pelvic pain during intercourse at least sometimes; sex being extremely or quite important; having a very or extremely physically pleasurable relationship with partner; and having a very or extremely emotionally satisfying relationship with partner. To facilitate presentation, we simplified our description of changes in these probabilities across the transition. For example, Ba decrease in arousal[ means a relative decrease in the odds of reporting frequent arousal. Importance of sex was modeled as an outcome and was also included as an ordinal covariate in multivariable models for all other functioning domains.
Random effects logistic regression models, which incorporated a random intercept term to account for the correlation between repeated measures from the same woman, were used to model the association between each outcome and menopause status, independently of aging and other covariates. All analyses were also run using conditional logistic regression models to verify that the random effects models were suitably estimating longitudinal effects. Results from the random effects models are shown because these allowed for the estimation and presentation of key cross-sectional effects, such as ethnicity. Adjusted estimates of the probability of each dichotomous outcome were estimated from random effects models, assuming a mean random effect of zero. STATA (version 8; STATA Corporation, College Station, TX) was used to perform all analyses. Table 1 presents characteristics of each analytic sample at baseline. By study design, almost half of the sample was white (47%), with the other half consisting of African American (28%), Hispanic (8.7%), Chinese (7.5%), and Japanese (8.5%) women. At baseline, 54% of the sample was premenopausal and 46% were early perimenopausal; mean age of the sample was 46.2 years. Table 2 shows the number of women in each menopause status over time. By the sixth annual follow-up visit, 26% of the women were postmenopausal. Seventy-eight percent of the women reported being sexually active at baseline and 71% at visit 06. Lack of a partner was the primary reason stated by women for not being sexually active, with 13% of the women at baseline and 17.3% at visit 06 reporting they were not sexually active because they did not have a partner.
RESULTS
The number of women providing sexual functioning information decreased somewhat during the course of the study. multivariable models to meet model assumptions that data are missing at random. Table 3 shows the response distribution for each outcome by menopause status. The dotted line shows how responses were categorized for analyses. In unadjusted analyses, menopause status was related to all sexual function outcomes. With adjustment for baseline age and time, the effect of the menopausal transition was no longer associated with the importance of sex, masturbation, physical pleasure, or emotional satisfaction. There remained significant decreases across the menopausal transition in the other four domains (desire, frequency, arousal, and pain) after adjustment for baseline age and time.
Unadjusted outcomes by menopausal transition

Multivariable analyses
Results of multivariable models with additional covariates related to sexual functioning are shown in Figure 1 and Table 4 . Figure 1 shows adjusted estimates of the probability of a woman reporting the dichotomous response for each outcome by menopause status.
The menopausal transition remained significantly associated with desire (P = 0.004) and vaginal/pelvic pain (P = 0.020). Sexual functioning among women who had a surgical menopause did not differ from premenopause. It should be noted, however, that this group was small (n = 119) and included women who were taking hormone therapy after surgery. For the most part, sexual functioning of current and former hormone therapy users did not differ from premenopause, although current and former users reported more pain, but also more physical pleasure. Current and former hormone users were similar to each other with respect to results for all sexual function outcomes.
Hot flashes were not related to any outcome and night sweats were only related to masturbation, with women who reported more frequent night sweats reporting less masturba- In contrast to findings that menopausal factors were unrelated to most aspects of sexual functioning, age, social, health, and psychological factors were highly related. The importance of sex, depression or anxiety, and race/ethnicity were related to all domains of sexual function. Women who rated sex as quite or extremely important reported more desire (OR [95% feeling sexual desire at least once per week; engaging in sexual intercourse at least once per week; having a very or extremely emotionally satisfying relationship; having a very or extremely physically pleasurable relationship; always or almost always feeling aroused during sexual activity; feeling vaginal or pelvic pain sometimes, always, or almost always during intercourse; and engaging in masturbation. Estimates are adjusted for all covariates shown in Table 3 . Pre, premenopausal; Peri, perimenopausal; Post, postmenopausal. .62]) than women who reported that sex was not important. Women with Center for Epidemiologic Studies Depression Scale score of 16 or more or with higher anxiety also reported worse sexual functioning on all domains. Self-assessed health was strongly and consistently related to all outcomes except masturbation, with worse health related to worse sexual functioning. Racial/ethnic differences were found for all domains. Chinese and Japanese women reported less importance, desire, masturbation, arousal, and more pain, whereas African American women reported greater importance, frequency, and pain, but less arousal, emotional satisfaction, and physical pleasure than did white women.
Other significant variables associated with sexual function were age, education, marital status, change in relationship status, and attitudes toward aging and menopause. Age and change in relationship were related to all outcomes except pain. Women who had a new relationship reported higher importance, desire, arousal, frequency, and emotional satisfaction, whereas women who lost a relationship reported more masturbation, less arousal, frequency, emotional satisfaction, and physical pleasure.
DISCUSSION
This large, community-based study of middle-aged women found a decrease in sexual desire, increase in painful intercourse beginning in the late perimenopause, and a temporary increase in masturbation during early perimenopause. These changes were independent of chronological aging; menopausal symptoms; and health, social, and psychological factors. In adjusted analyses, menopausal transition was unrelated to arousal, frequency of sexual activity, physical pleasure, or satisfaction with partner. Although vasomotor symptoms were largely unrelated to sexual functioning, vaginal dryness was highly associated with pain and lower arousal, emotional satisfaction, and physical pleasure. The most important variable related to sexual functioning was importance of sex, which was highly related to all outcomes. Psychological status, physical health, and relationship status were also important.
We did not find that hormone therapy users reported better sexual functioning, but these results must be interpreted with caution. Current and former hormone therapy users reported more physical pleasure, but also more vaginal/pelvic pain. However, the timing of hormone therapy in relation to the experience of pain and desire was not assessed, and we could not determine whether hormone therapy provided any diminution of pain or increase in desire. The reason for hormone therapy use was not available, and menopause status was not determinable for women who initiated hormone therapy before the final menstrual period. The consistent pattern of results for both current and former users suggest Bconfounding by indication.[ That is, women who have a troublesome symptom (such as vaginal/pelvic pain) chose to take estrogen to treat the problem, making it appear that pain is an effect of hormone therapy. We should note, however, that the present study was not designed to determine the effect of hormone therapy on sexual functioning, a question best addressed in a clinical trial in which treatment assignment is random.
Findings of an association between menopausal transition and an increase in vaginal or pelvic pain and a decrease in sexual desire, independent of aging and a range of covariates, strengthen results from cross-sectional studies that have shown greater pain 16, 35, 36 and lower sexual interest or desire among perimenopausal or postmenopausal women. 9, 11, 12, 20, 35 The increase in masturbation during early perimenopause is an interesting finding and may be related to the concurrent increase in painful intercourse. The decline in masturbation postmenopause may be related to the concurrent decline in desire. The lack of an association between menopausal transition and frequency of sexual intercourse or satisfaction with partner is also consistent with other cross-sectional research 12, 19, 20 and, together with the lack of an association with importance of sex and arousal, suggests that these domains of sexual function are not directly related to the menopausal transition.
These results suggest a plausible causal pattern underlying declines in sexual functioning because increases in pain may lead to lowered sexual desire. Vulvovaginal epithelium is rich in estrogen receptors, and estrogens are a necessity for urogenital maturation, maintenance, and genital vascular congestion during arousal. 37 Lower estrogen levels in the late transition may lead to decreased vascular engorgement and vaginal secretions during sex, resulting in a diminished sense of pleasure from subjective arousal and a disruption in the intimacy-based sexual response cycle. 38 These results from SWAN highlight the importance of including social, health, and relationship factors in the context of menopause and sexual functioning. These factors and, in particular, feelings toward one's partner or starting a new relationship have also been identified by others as highly important. 1,10,19,20,39<42 Similar to the Melbourne Women's Midlife Health Project, we found declines in all areas of sexual functioning in unadjusted analyses of menopause status. Controlling only for age, the Melbourne Women's Midlife Health Project also found greater declines in sexual functioning among 197 women who transitioned from premenopause to postmenopause compared with women who remained premenopausal. 4 Subsequent analyses from the Melbourne study found that previous sexual function and relationship factors were more important determinants of libido and sexual responsiveness than estradiol level. 6 Although the Penn Ovarian Aging Study found an increase in overall sexual dysfunction with advanced menopause status, several critical factors such as health, vaginal dryness, aging, and relationship status were not assessed. 10 450 Menopause, Vol. 16 Despite controlling for a wide range of variables, we found racial/ethnic differences for all outcomes. African American women reported higher frequency of sexual intercourse, consistent with other research showing that African American women are more likely to engage in vaginal intercourse than other sexual activities such as oral or anal intercourse. 2, 26, 43, 44 Findings for Chinese and Japanese women are consistent with data showing that Asian women tend to engage in fewer different manifestations of sexuality than Western women and that sexuality is more linked to procreation in Asian cultures. 45 Results are also consistent with findings from the Global Study of Sexual Attitudes and Behaviors, which found that Asian countries reported low levels of satisfaction with sexual function and the importance of sex. 46 These findings suggest that sexual behavior has a strong cultural component.
Several limitations of these data should be mentioned. First, the questionnaire did not include items on the sexual limitations of the woman's partner, an important consideration for aging women. Second, the sexual functioning questionnaire was not one of the more newly developed, validated questionnaires. 35, 47 However, the items were derived from previously published questionnaires and tap the primary domains of sexual functioning assessed by these measures. Third, as is inevitable in longitudinal studies, some participants missed visits or were lost to follow-up, resulting in missing data. The analytic methods used are relatively robust to missing data, and multivariable models incorporated numerous factors strongly associated with the likelihood of data being missing. However, the potential impact of missing data on analysis results should be considered. Future research in this area needs to examine partner limitations more closely and follow women through the early postmenopausal years. This analysis did not consider the possible relation between sexuality and sex steroid levelsVa complex question that demands a detailed analysis and will be the subject of future SWAN work.
CONCLUSIONS
These results from SWAN have clinical relevance. Therapy to prevent menopausal transitionYassociated vaginal pain may help slow or prevent subsequent/simultaneous declines in sexual desire. The strong associations of psychological status, physical health, and social factors with sexual function underscore the clinical imperative to explore and address these factors when discussing women's concerns regarding sexual dysfunction. The very strong association of the importance of sex with all domains of sexual function suggests that asking women about the importance of sex may be a cornerstone of the management of the sexual concerns of midlife women.
